Bu Kunpeng, Shi Zeyan, Lu Yang, Zhao Juan, Li Bixun
Department of Comprehensive Internal Medicine, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning.
Department of Hematology, First Hospital Affiliated to Guangxi Medical University, Guangxi.
Medicine (Baltimore). 2019 Apr;98(16):e15245. doi: 10.1097/MD.0000000000015245.
Urothelial carcinoma, also named transitional cell carcinoma, is the most frequent occurring malignancy in the urinary system. It mainly invades the surrounding tissues and metastasizes to distant organs in later stages.
Here, we presented an unusual case of occult urothelial carcinoma primarily manifested as a multiorgan metastatic cancer in a 59-year-old man. The patient complained of pain on the left thigh root for a month. The imaging and histopathological examination revealed multiple malignancies in lung, bone, and liver.
The histological evaluation and the immunohistochemistry (IHC) profile of liver, lung, and bone were consistent with the diagnosis of metastases from the original urothelial cancer, while imaging examination was not able to detect a primary lesion in the urinary system.
Based on the mutation of STK11 M51Ifs*106 detected by next generation sequencing (NGS), we started targeted therapy with everolimus.
The patient deteriorated after 3 months of treatment and passed away.
In this initial report of occult urothelial carcinoma, we obtained information on genetic variations of tumor tissue which could provide important information for subsequent studies on this kind of disease.
尿路上皮癌,也称为移行细胞癌,是泌尿系统中最常见的恶性肿瘤。它主要侵犯周围组织,并在后期转移至远处器官。
在此,我们报告了一例罕见的隐匿性尿路上皮癌病例,主要表现为一名59岁男性的多器官转移性癌症。患者主诉左大腿根部疼痛一个月。影像学和组织病理学检查显示肺、骨和肝脏存在多处恶性肿瘤。
肝脏、肺和骨的组织学评估及免疫组织化学(IHC)特征与原发性尿路上皮癌转移的诊断一致,而影像学检查未能在泌尿系统中检测到原发性病变。
基于下一代测序(NGS)检测到的STK11 M51Ifs*106突变,我们开始使用依维莫司进行靶向治疗。
治疗3个月后患者病情恶化并去世。
在这份隐匿性尿路上皮癌的初步报告中,我们获得了肿瘤组织基因变异的信息,这可为后续此类疾病的研究提供重要信息。